Northern Trust Corp Allakos Inc. Transaction History

Northern Trust Corp

$761 Billion
Q3 2025

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$0.62 - $1.5 $9,424 - $22,801	15,201 Added 10.19%	164,355 $198,000
Q3 2024 Nov 13, 2024	SELL	$0.54 - $0.92 $211,190 - $359,806	-391,094 Reduced 72.39%	149,154 $96,000
Q2 2024 Aug 14, 2024	SELL	$1.0 - $1.45 $16,580 - $24,041	-16,580 Reduced 2.98%	540,248 $540,000
Q1 2024 May 14, 2024	SELL	$1.02 - $3.23 $8,725 - $27,629	-8,554 Reduced 1.51%	556,828 $701,000
Q4 2023 Feb 13, 2024	SELL	$1.72 - $3.18 $22,931 - $42,395	-13,332 Reduced 2.3%	565,382 $1.54 Million

Q3 2023 Nov 13, 2023	SELL	$2.13 - $5.55 $3,731 - $9,723	-1,752 Reduced 0.3%	578,714 $1.31 Million
Q2 2023 Aug 11, 2023	BUY	$3.6 - $5.25 $1.52 Million - $2.22 Million	422,524 Added 267.52%	580,466 $2.53 Million
Q1 2023 May 15, 2023	SELL	$4.3 - $8.27 $14,220 - $27,348	-3,307 Reduced 2.05%	157,942 $702,000
Q4 2022 Feb 13, 2023	BUY	$5.66 - $8.42 $222,222 - $330,586	39,262 Added 32.19%	161,249 $1.36 Million
Q3 2022 Nov 14, 2022	BUY	$3.02 - $6.12 $180,206 - $365,186	59,671 Added 95.76%	121,987 $747,000
Q2 2022 Aug 12, 2022	SELL	$2.6 - $6.14 $708,193 - $1.67 Million	-272,382 Reduced 81.38%	62,316 $195,000
Q1 2022 May 13, 2022	SELL	$5.08 - $9.81 $66,857 - $129,109	-13,161 Reduced 3.78%	334,698 $1.91 Million
Q4 2021 Feb 08, 2022	SELL	$8.55 - $111.89 $15,885 - $207,891	-1,858 Reduced 0.53%	347,859 $3.41 Million
Q3 2021 Nov 15, 2021	BUY	$76.53 - $110.43 $2.73 Million - $3.94 Million	35,698 Added 11.37%	349,717 $37 Million
Q2 2021 Aug 13, 2021	BUY	$85.37 - $114.1 $650,177 - $868,985	7,616 Added 2.49%	314,019 $26.8 Million
Q1 2021 May 12, 2021	SELL	$109.73 - $153.66 $1.22 Million - $1.71 Million	-11,143 Reduced 3.51%	306,403 $35.2 Million
Q4 2020 Feb 11, 2021	BUY	$79.58 - $152.45 $1.4 Million - $2.67 Million	17,539 Added 5.85%	317,546 $44.5 Million
Q3 2020 Nov 16, 2020	SELL	$66.43 - $90.99 $824,662 - $1.13 Million	-12,414 Reduced 3.97%	300,007 $24.4 Million
Q2 2020 Aug 14, 2020	BUY	$44.04 - $80.69 $2.39 Million - $4.37 Million	54,203 Added 20.99%	312,421 $22.5 Million
Q1 2020 May 14, 2020	BUY	$44.49 - $93.39 $161,320 - $338,632	3,626 Added 1.42%	258,218 $11.5 Million
Q4 2019 Feb 14, 2020	SELL	$66.49 - $137.73 $397,676 - $823,763	-5,981 Reduced 2.3%	254,592 $24.3 Million
Q3 2019 Nov 13, 2019	BUY	$31.0 - $89.73 $2.8 Million - $8.11 Million	90,430 Added 53.15%	260,573 $20.5 Million
Q2 2019 Aug 13, 2019	BUY	$36.0 - $44.73 $138,492 - $172,076	3,847 Added 2.31%	170,143 $7.37 Million
Q1 2019 May 13, 2019	BUY	$33.79 - $51.99 $1.8 Million - $2.78 Million	53,393 Added 47.29%	166,296 $6.74 Million
Q4 2018 Feb 12, 2019	BUY	$31.59 - $62.65 $126,170 - $250,224	3,994 Added 3.67%	112,903 $5.9 Million
Q3 2018 Nov 14, 2018	BUY	$31.25 - $47.64 $3.4 Million - $5.19 Million	108,909 New	108,909 $4.9 Million

Others Institutions Holding ALLK

# of Institutions

Shares Held

1.29M

Call Options Held

Put Options Held

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $28M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account